Murayama, Kayoko
67  results:
Search for persons X
?
2

Importance of TKI treatment duration in treatment-free remi..:

Yoshida, Chikashi ; Yamaguchi, Hiroki ; Doki, Noriko...
International Journal of Hematology.  117 (2023)  5 - p. 694-705 , 2023
 
?
5

Initial extramedullary myeloma impacts overall survival via..:

Takei, Hisashi ; Koiso, Hiromi ; Matsumoto, Morio...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e194-e195 , 2019
 
?
6

Bortezomib maintenance therapy in transplant-ineligible mye..:

Isoda, Atsushi ; Murayama, Kayoko ; Ito, Shigeki...
International Journal of Hematology.  108 (2018)  1 - p. 39-46 , 2018
 
?
7

Clinical management and outcomes of completely resected sta..:

Yokohama, Akihiko ; Hashimoto, Yoko ; Takizawa, Makiko...
Journal of Clinical and Experimental Hematopathology.  58 (2018)  1 - p. 10-16 , 2018
 
?
8

Prognostic impact of trisomy 21 in follicular lymphoma:

Mitsui, Takeki ; Yokohama, Akihiko ; Koiso, Hiromi...
British Journal of Haematology.  184 (2018)  4 - p. 570-577 , 2018
 
?
9

Retrospective analysis of prognostic factors for Waldenstrӧ..:

Saito, Akio ; Isoda, Atsushi ; Kojima, Masaru...
International Journal of Hematology.  106 (2017)  5 - p. 681-690 , 2017
 
?
10

Primary Hepatic and Hepatosplenic Diffuse Large B-Cell Lymp..:

Kashimura, Makoto ; Murayama, Kayoko ; Kojima, Masaru
International Journal of Surgical Pathology.  21 (2013)  5 - p. 531-534 , 2013
 
?
11

Prognostic Importance of the Soluble Form of IL-2 Receptor^..:

Hashimoto, Yoko ; Yokohama, Akihiko ; Saitoh, Akio...
Journal of Clinical and Experimental Hematopathology.  53 (2013)  3 - p. 197-205 , 2013
 
?
 
?
15

Atypical Lymphoplasmacytic and Immunoblastic Proliferation ..:

Kojima, Masaru ; Nakamura, Naoya ; Tsukamoto, Norihumi...
Journal of Clinical and Experimental Hematopathology.  50 (2010)  2 - p. 113-119 , 2010
 
1-15